move johnson johnson widely expected firm pay 76 guidant share 6 wednesdays closing pricepharmaceutical giant johnson johnson agreed buy medical technology firm guidant 254bn Â£13bnanalysts said deal aimed offsetting johnson johnsons reliance slowing businessa number johnson johnsons products facing patent expirations company battling fierce competition generic products
